BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35832325)

  • 1. Vaccine-Linked Chemotherapy Approach: Additive Effects of Combining the
    Imhof D; Pownall WR; Schlange C; Monney C; Ortega-Mora LM; Ojo KK; Van Voorhis WC; Oevermann A; Hemphill A
    Front Vet Sci; 2022; 9():901056. PubMed ID: 35832325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with a Multivalent
    Imhof D; Pownall W; Hänggeli KPA; Monney C; Román LR; Ortega-Mora LM; Forterre F; Oevermann A; Hemphill A
    Vaccines (Basel); 2023 Jan; 11(1):. PubMed ID: 36680001
    [No Abstract]   [Full Text] [Related]  

  • 3. A
    Imhof D; Pownall WR; Monney C; Oevermann A; Hemphill A
    Vaccines (Basel); 2021 Nov; 9(12):. PubMed ID: 34960146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of a Novel
    Pownall WR; Imhof D; Trigo NF; Ganal-Vonarburg SC; Plattet P; Monney C; Forterre F; Hemphill A; Oevermann A
    Front Cell Infect Microbiol; 2021; 11():675219. PubMed ID: 34650932
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro activity, safety and in vivo efficacy of the novel bumped kinase inhibitor BKI-1748 in non-pregnant and pregnant mice experimentally infected with Neospora caninum tachyzoites and Toxoplasma gondii oocysts.
    Imhof D; Anghel N; Winzer P; Balmer V; Ramseier J; Hänggeli K; Choi R; Hulverson MA; Whitman GR; Arnold SLM; Ojo KK; Van Voorhis WC; Doggett JS; Ortega-Mora LM; Hemphill A
    Int J Parasitol Drugs Drug Resist; 2021 Aug; 16():90-101. PubMed ID: 34030110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of BKI-1294 Therapy in Mice Infected With the Apicomplexan Parasite
    Winzer P; Imhof D; Anghel N; Ritler D; Müller J; Boubaker G; Aguado-Martinez A; Ortega-Mora LM; Ojo KK; VanVoorhis WC; Hemphill A
    Front Vet Sci; 2020; 7():587570. PubMed ID: 33195616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two Novel Calcium-Dependent Protein Kinase 1 Inhibitors Interfere with Vertical Transmission in Mice Infected with Neospora caninum Tachyzoites.
    Müller J; Aguado-Martínez A; Balmer V; Maly DJ; Fan E; Ortega-Mora LM; Ojo KK; Van Voorhis WC; Hemphill A
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of the bumped kinase inhibitor BKI-1553 in pregnant sheep experimentally infected with Neospora caninum tachyzoites.
    Sánchez-Sánchez R; Ferre I; Re M; Vázquez P; Ferrer LM; Blanco-Murcia J; Regidor-Cerrillo J; Pizarro Díaz M; González-Huecas M; Tabanera E; García-Lunar P; Benavides J; Castaño P; Hemphill A; Hulverson MA; Whitman GR; Rivas KL; Choi R; Ojo KK; Barrett LK; Van Voorhis WC; Ortega-Mora LM
    Int J Parasitol Drugs Drug Resist; 2018 Apr; 8(1):112-124. PubMed ID: 29501973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A short-term treatment with BKI-1294 does not protect foetuses from sheep experimentally infected with Neospora caninum tachyzoites during pregnancy.
    Sánchez-Sánchez R; Ferre I; Re M; Pérez-Arroyo B; Cleofé-Resta D; García VH; Díaz MP; Ferrer LM; Ruiz H; Vallejo-García R; Benavides J; Hulverson MA; Choi R; Whitman GR; Hemphill A; Van Voorhis WC; Ortega-Mora LM
    Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():176-185. PubMed ID: 34655903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endochin-like quinolones (ELQs) and bumped kinase inhibitors (BKIs): Synergistic and additive effects of combined treatments against Neospora caninum infection in vitro and in vivo.
    Anghel N; Imhof D; Winzer P; Balmer V; Ramseier J; Haenggeli K; Choi R; Hulverson MA; Whitman GR; Arnold SLM; Ojo KK; Van Voorhis WC; Doggett JS; Ortega-Mora LM; Hemphill A
    Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():92-106. PubMed ID: 34482255
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Winzer P; Anghel N; Imhof D; Balmer V; Ortega-Mora LM; Ojo KK; Van Voorhis WC; Müller J; Hemphill A
    Pathogens; 2020 May; 9(5):. PubMed ID: 32429314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of the bumped kinase inhibitor BKI-1708 against the cyst-forming apicomplexan parasites Toxoplasma gondii and Neospora caninum in vitro and in experimentally infected mice.
    de Sousa MCF; Imhof D; Hänggeli KPA; Choi R; Hulverson MA; Arnold SLM; Van Voorhis WC; Fan E; Roberto SS; Ortega-Mora LM; Hemphill A
    Int J Parasitol Drugs Drug Resist; 2024 Jun; 25():100553. PubMed ID: 38917582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of mice against experimental Neospora caninum infection using NcSAG1- and NcSRS2-based recombinant antigens and DNA vaccines.
    Cannas A; Naguleswaran A; Müller N; Eperon S; Gottstein B; Hemphill A
    Parasitology; 2003 Apr; 126(Pt 4):303-12. PubMed ID: 12741509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of vertical transmission of Neospora caninum in C57BL/6 mice vaccinated with Brucella abortus strain RB51 expressing N. caninum protective antigens.
    Ramamoorthy S; Sanakkayala N; Vemulapalli R; Jain N; Lindsay DS; Schurig GS; Boyle SM; Sriranganathan N
    Int J Parasitol; 2007 Nov; 37(13):1531-8. PubMed ID: 17575983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A vaccine formulation combining rhoptry proteins NcROP40 and NcROP2 improves pup survival in a pregnant mouse model of neosporosis.
    Pastor-Fernández I; Arranz-Solís D; Regidor-Cerrillo J; Álvarez-García G; Hemphill A; García-Culebras A; Cuevas-Martín C; Ortega-Mora LM
    Vet Parasitol; 2015 Jan; 207(3-4):203-15. PubMed ID: 25579396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites.
    Debache K; Alaeddine F; Guionaud C; Monney T; Müller J; Strohbusch M; Leib SL; Grandgirard D; Hemphill A
    Int J Parasitol; 2009 Oct; 39(12):1373-84. PubMed ID: 19447110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common Molecular Targets of a Quinolone Based Bumped Kinase Inhibitor in
    Müller J; Anghel N; Imhof D; Hänggeli K; Uldry AC; Braga-Lagache S; Heller M; Ojo KK; Ortega-Mora LM; Van Voorhis WC; Hemphill A
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216497
    [No Abstract]   [Full Text] [Related]  

  • 18. Neospora caninum calcium-dependent protein kinase 1 is an effective drug target for neosporosis therapy.
    Ojo KK; Reid MC; Kallur Siddaramaiah L; Müller J; Winzer P; Zhang Z; Keyloun KR; Vidadala RS; Merritt EA; Hol WG; Maly DJ; Fan E; Van Voorhis WC; Hemphill A
    PLoS One; 2014; 9(3):e92929. PubMed ID: 24681759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro and In Vivo Effects of the Bumped Kinase Inhibitor 1294 in the Related Cyst-Forming Apicomplexans Toxoplasma gondii and Neospora caninum.
    Winzer P; Müller J; Aguado-Martínez A; Rahman M; Balmer V; Manser V; Ortega-Mora LM; Ojo KK; Fan E; Maly DJ; Van Voorhis WC; Hemphill A
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6361-74. PubMed ID: 26248379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with
    Fereig RM; Abdelbaky HH; Nishikawa Y
    Vaccines (Basel); 2021 Feb; 9(2):. PubMed ID: 33671937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.